How well do European patients understand cancer-associated thrombosis? A patient survey
Ongoing concerns regarding the morbidity and mortality from cancer-associated thrombosis led the European Cancer Patient Coalition (ECPC), the voice of cancer patients across Europe, to create a pan-European cancer-associated awareness patient survey to assess cancer-associated thrombosis (CAT) know...
Main Authors: | Anna Falanga, Charis Girvalaki, Manuel Monreal, Jacob C Easaw, Annie Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294222000478 |
Similar Items
-
Treatment and Prevention of Cancer-Associated Thrombosis in Frail Patients: Tailored Management
by: Florian Scotté, et al.
Published: (2019-01-01) -
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines
by: Anna Falanga, et al.
Published: (2023-01-01) -
Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade
by: Andriani Charpidou, et al.
Published: (2024-01-01) -
Current state of non-hematologic cancer-associated thrombosis at a tertiary care hospital in India
by: Mukul Aggarwal, et al.
Published: (2023-01-01) -
Incidence, Therapy, and Bleeding Risk—Cancer- Associated Thrombosis in Patients with Glioblastoma
by: Viktoria Muster, et al.
Published: (2020-05-01)